1-12 of 12
Deric L. Wheeler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C174: MerTK as a putative biomarker for treatment response in triple negative breast cancer

Bridget E Mehall, Mari Iida, Kourtney L Kostecki, Jillian M Adams, Deric L Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): C174.
https://doi.org/10.1158/1535-7163.TARG-23-C174
Published: 01 December 2023
View article titled, Abstract C174: MerTK as a putative biomarker for treatment response in triple negative breast cancer
Journal Articles

Abstract A128: AXL mediates cetuximab resistance through tyrosine 821 and activation of c-Abl kinase in head and neck cancer

Nellie K McDaniel, Mari Iida, Kwangok P Nickel, Tamara S Rodems, Adam D Swick, Prashanth J Prabakaran, Jaimee C Eckers-Kubatzke, Noah B Welke, Carlene Kranjac, Alison E Schulz, Randy J Kimple, Ravi Salgia, Deric L Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): A128.
https://doi.org/10.1158/1535-7163.TARG-19-A128
Published: 01 December 2019
View article titled, Abstract A128: AXL mediates cetuximab resistance through tyrosine 821 and activation of c-Abl kinase in head and neck cancer
Journal Articles

Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer

Toni M. Brand, Mari Iida, Emily F. Dunn, Neha Luthar, Kellie T. Kostopoulos, Kelsey L. Corrigan, Matthew J. Wleklinski, David Yang, Kari B. Wisinski, Ravi Salgia, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (4): 868.
https://doi.org/10.1158/1535-7163.MCT-18-1183
Published: 01 April 2019
View article titled, Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer
Open the PDF for Correction: Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-negative Breast Cancer in another window
Journal Articles

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents

Nellie K. McDaniel, Christopher T. Cummings, Mari Iida, Justus Hülse, Hannah E. Pearson, Eleana Vasileiadi, Rebecca E. Parker, Rachel A. Orbuch, Olivia J. Ondracek, Noah B. Welke, Grace H. Kang, Kurtis D. Davies, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Paul M. Harari, Randall J. Kimple, Deborah DeRyckere, Douglas K. Graham, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (11): 2297–2308.
https://doi.org/10.1158/1535-7163.MCT-17-1239
Published: 02 November 2018
View article titled, MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Open the PDF for MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents in another window
Includes: Supplementary data
Journal Articles

Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol

Hannah E. Pearson, Mari Iida, Rachel A. Orbuch, Nellie K. McDaniel, Kwangok P. Nickel, Randall J. Kimple, Jack L. Arbiser, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1): 204–214.
https://doi.org/10.1158/1535-7163.MCT-17-0384
Published: 01 January 2018
View article titled, Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol
Open the PDF for Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol in another window
Journal Articles

Abstract A140: MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents

Nellie K. McDaniel, Christopher T. Cummings, Toni M. Brand, Mari Iida, Justus Hulse, Hannah E. Pearson, Rachel A. Orbuch, Olivia J. Ondracek, Kurtis D. Davies, Parkash Gill, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Randall J. Kimple, Paul M. Harari, Deborah DeRyckere, Douglas K. Graham, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A140.
https://doi.org/10.1158/1535-7163.TARG-17-A140
Published: 01 January 2018
View article titled, Abstract A140: MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents
Journal Articles

Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC

Adam D. Swick, Prashanth J. Prabakaran, Margot C. Miller, Amal M. Javaid, Michael M. Fisher, Emmanuel Sampene, Irene M. Ong, Rong Hu, Mari Iida, Kwangok P. Nickel, Justine Y. Bruce, Deric L. Wheeler, Randall J. Kimple
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1257–1268.
https://doi.org/10.1158/1535-7163.MCT-17-0115
Published: 04 July 2017
View article titled, Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC
Open the PDF for Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC in another window
Includes: Supplementary data
Journal Articles

Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab

Mari Iida, Harsh Bahrar, Toni M. Brand, Hannah E. Pearson, John P. Coan, Rachel A. Orbuch, Bailey G. Flanigan, Adam D. Swick, Prashanth J. Prabakaran, Johan Lantto, Ivan D. Horak, Michael Kragh, Ravi Salgia, Randy J. Kimple, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (9): 2175–2186.
https://doi.org/10.1158/1535-7163.MCT-16-0012
Published: 01 September 2016
View article titled, Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab
Open the PDF for Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab in another window
Journal Articles

Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer

Toni M. Brand, Mari Iida, Emily F. Dunn, Neha Luthar, Kellie T. Kostopoulos, Kelsey L. Corrigan, Matthew J. Wleklinski, David Yang, Kari B. Wisinski, Ravi Salgia, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (5): 1356–1368.
https://doi.org/10.1158/1535-7163.MCT-13-1021
Published: 05 May 2014
View article titled, Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer
Open the PDF for Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer

Cleo E. Rolle, Rajani Kanteti, Mosmi Surati, Suvobroto Nandi, Immanuel Dhanasingh, Soheil Yala, Maria Tretiakova, Qudsia Arif, Todd Hembrough, Toni M. Brand, Deric L. Wheeler, Aliya N. Husain, Everett E. Vokes, Ajit Bharti, Ravi Salgia
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2014) 13 (3): 576–584.
https://doi.org/10.1158/1535-7163.MCT-13-0109
Published: 09 March 2014
View article titled, Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer
Open the PDF for Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer in another window
Journal Articles

Abstract A146: Targeting AKT signaling overcomes acquired resistance to cetuximab in non-small lung cancer cells.

Mari Iida, David A. Campbell, Toni M. Brand, Chunrong Li, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A146.
https://doi.org/10.1158/1535-7163.TARG-11-A146
Published: 12 November 2011
View article titled, Abstract A146: Targeting AKT signaling overcomes acquired resistance to cetuximab in non-small lung cancer cells.
Journal Articles

Abstract C43: Dasatinib resensitizes Kras mutant colorectal tumors to cetuximab

Emily F. Dunn, Mari Iida, Eric Armstrong, Deric L. Wheeler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C43.
https://doi.org/10.1158/1535-7163.TARG-09-C43
Published: 10 December 2009
View article titled, Abstract C43: Dasatinib resensitizes Kras mutant colorectal tumors to cetuximab